ELEVANCE HEALTH INC

ELVNYSE

🏆 #163 by market capEarnings Oct 19 · PreUS Equity

$390.37▼ $7.18 (−1.84%)

Live

1h—

24h▼ 1.8%

7d—

14d—

30d—

1y—

🏦Market Cap

$84.66B

Mid Cap

📈Revenue Growth (YoY)

+6.3%

Slowing

📊Gross Margin

—

💵FCF Margin

3.2%

Moderate

⚖️P/S Ratio

0.4x

Cheap

Otter Score

Fair

No chart data available for ELV.

Trading Snapshot

Day Range: $388.33 – $394.75
52-Week Range: $274.84 – $436.24
Volume: $2.35B
Avg Volume: $2.53B
Shares Outstanding: 216.9M
Next Earnings: Sep 17, 2026

Fundamentals Snapshot

Annual Revenue: $199.13B
Last Q Revenue: $50.47B
P/E Ratio: 17.4
P/S Ratio: 0.4x
EPS (TTM): $22.50
Dividend Yield: 1.74%

Why Investors Own ELV

✓High-growth profile — revenue up +13.3% YoY with expanding US Equity exposure.
✓Healthy economics — 72% gross margin and 8% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$199.13B▲ +13.9% YoY

Gross Margin (TTM)

72.1%▲ +2.2% YoY

Operating Income (TTM)

$29.07B▲ +13.9% YoY

Free Cash Flow (TTM)

$15.13B▲ +13.9% YoY

About ELEVANCE HEALTH INC

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.

🦦